False positivity of FDG-PET/CT in a child with Hodgkin disease

Beker D. B., Berrak S. G., Canpolat C., Tugtepe H., ÖNEŞ T., Tecimer T.

PEDIATRIC BLOOD & CANCER, cilt.50, sa.4, ss.881-883, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Sayı: 4
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1002/pbc.21197
  • Dergi Adı: PEDIATRIC BLOOD & CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.881-883
  • Anahtar Kelimeler: false positivity, FDG-PET/CT, Hodgkin, lymphoma, COMPUTED-TOMOGRAPHY, EMISSION-TOMOGRAPHY, LYMPHOMA, F-18-FDG, UTILITY
  • Marmara Üniversitesi Adresli: Evet

Özet

Role of Positron Emission Tomography (PET) with F-18-2-fluoro-2-deoxy-D-glucose (FDG) in staging of Hodgkin disease is well established despite several controversies. We report a Stage III Hodgkin lymphoma patient with false positive FDG-PET/CT results. Seven-year-old male with Hodgkin lymphoma was in remission at end of chemotherapy. At third and fourth months of postchemotherapy follow-up, increased gallium uptake and positive FDG-PET/CT revealed lymphoid hyperplasia. He has been followed for 21 months without any evidence of disease. Despite its documented benefit, we believe that results of FDG-PET/CT should be interpreted with great caution in order to avoid unnecessary interventions.